$82.28
00.00%
At Close: -
$82.28
00.00%
After Hours: 4:19 PM EDT
15 minutes delayed
LeMaitre Vascular
LMATNASDAQ
LeMaitre Vascular (NASDAQ:LMAT) Stock, Analyst Ratings, Price Targets, Predictions
LeMaitre Vascular Inc has a consensus price target of $66.78, established from looking at the 15 latest analyst ratings. The last 3 analyst ratings were released from Roth MKM, Barrington Research, and JMP Securities on May 31, 2024, May 3, 2024, and May 3, 2024. With an average price target of $85.33 between Roth MKM, Barrington Research, and JMP Securities, there's an implied 3.71% upside for LeMaitre Vascular Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Roth MKM
Barrington Research
JMP Securities
Stifel
Keybanc
1calculated from analyst ratings
Analyst Ratings for LeMaitre Vascular
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/31/2024 | Buy Now | 21.54% | Roth MKM | Jason Wittes | → $100 | Reinstates | → Buy | Get Alert |
| 05/03/2024 | Buy Now | -3.99% | Barrington Research | Michael Petusky | $69 → $79 | Maintains | Outperform | Get Alert |
| 05/03/2024 | Buy Now | -6.42% | JMP Securities | Daniel Stauder | $72 → $77 | Maintains | Market Outperform | Get Alert |
| 04/26/2024 | Buy Now | -8.85% | Stifel | Rick Wise | $59 → $75 | Upgrade | Hold → Buy | Get Alert |
| 02/28/2024 | Buy Now | -16.14% | Barrington Research | Michael Petusky | $66 → $69 | Maintains | Outperform | Get Alert |
| 02/06/2024 | Buy Now | — | Keybanc | Brett Fishbin | — | Initiates | → Sector Weight | Get Alert |
| 10/23/2023 | Buy Now | -27.08% | JMP Securities | Daniel Stauder | → $60 | Initiates | → Market Outperform | Get Alert |
| 09/06/2023 | Buy Now | -14.92% | Oppenheimer | Suraj Kalia | → $70 | Initiates | → Outperform | Get Alert |
| 08/03/2023 | Buy Now | -18.57% | Jefferies | Anthony Petrone | $63 → $67 | Downgrade | Buy → Hold | Get Alert |
| 08/02/2023 | Buy Now | -8.85% | Lake Street | Brooks O'Neil | $65 → $75 | Maintains | Buy | Get Alert |
| 08/02/2023 | Buy Now | -19.79% | Barrington Research | Michael Petusky | $62 → $66 | Maintains | Outperform | Get Alert |
| 05/03/2023 | Buy Now | -24.65% | Barrington Research | Michael Petusky | → $62 | Upgrade | Market Perform → Outperform | Get Alert |
| 10/28/2022 | Buy Now | — | Barrington Research | Michael Petusky | — | Downgrade | Outperform → Market Perform | Get Alert |
| 09/16/2021 | Buy Now | -14.92% | Jefferies | Anthony Petrone | — | Initiates | → Buy | Get Alert |
| 08/03/2021 | Buy Now | -29.51% | Roth Capital | Scott Henry | — | Maintains | Neutral | Get Alert |
FAQ
What is the target price for LeMaitre Vascular (LMAT) stock?
The latest price target for LeMaitre Vascular (NASDAQ:LMAT) was reported by Roth MKM on May 31, 2024. The analyst firm set a price target for $100.00 expecting LMAT to rise to within 12 months (a possible 21.54% upside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for LeMaitre Vascular (LMAT)?
The latest analyst rating for LeMaitre Vascular (NASDAQ:LMAT) was provided by Roth MKM, and LeMaitre Vascular their buy rating.
When was the last upgrade for LeMaitre Vascular (LMAT)?
The last upgrade for LeMaitre Vascular Inc happened on April 26, 2024 when Stifel raised their price target to $75. Stifel previously had a hold for LeMaitre Vascular Inc.
When was the last downgrade for LeMaitre Vascular (LMAT)?
The last downgrade for LeMaitre Vascular Inc happened on August 3, 2023 when Jefferies changed their price target from $63 to $67 for LeMaitre Vascular Inc.
When is the next analyst rating going to be posted or updated for LeMaitre Vascular (LMAT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of LeMaitre Vascular, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for LeMaitre Vascular was filed on May 31, 2024 so you should expect the next rating to be made available sometime around May 31, 2025.
Is the Analyst Rating LeMaitre Vascular (LMAT) correct?
While ratings are subjective and will change, the latest LeMaitre Vascular (LMAT) rating was a with a price target of $0.00 to $100.00. The current price LeMaitre Vascular (LMAT) is trading at is $82.28, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.